ERİN, N. Et Al. 2015. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists. BREAST CANCER RESEARCH AND TREATMENT , vol.150, no.1 , 57-69.

ERİN, N., NIZAM, E., TANRIÖVER, G., & KÖKSOY, S., (2015). Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists. BREAST CANCER RESEARCH AND TREATMENT , vol.150, no.1, 57-69.

ERİN, NURAY Et Al. "Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists," BREAST CANCER RESEARCH AND TREATMENT , vol.150, no.1, 57-69, 2015

ERİN, NURAY Et Al. "Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists." BREAST CANCER RESEARCH AND TREATMENT , vol.150, no.1, pp.57-69, 2015

ERİN, N. Et Al. (2015) . "Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists." BREAST CANCER RESEARCH AND TREATMENT , vol.150, no.1, pp.57-69.

@article{article, author={NURAY ERİN Et Al. }, title={Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2015, pages={57-69} }